Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

The EuroPCR 2024 meeting May 14-17 in Paris included four days of late-breaking interventional cardiology science presentations featured 12,100 participants, more than 550 educational sessions and 12 live cases. Photo courtesy of EuroPCR

5 takeaways from late-breaking studies at EuroPCR

The Society for Cardiovascular Angiography and Interventions offers its top five key takeaways from the EuroPCR 2024 meeting last week.

May 20, 2024
Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule. 

Hospital to pay $24.3M over TAVR allegations

According to a whistleblower, Cape Cod Hospital performed hundreds of TAVR procedures without following specific government requirements.

May 17, 2024
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve

Myval TAVR valve noninferior to similar devices from Medtronic, Edwards after 30 days

The balloon-expandable valve is already approved for use in India and Europe. New data presented at EuroPCR 2024 in Paris compared it to contemporary devices seen by many as the gold standard for TAVR care. 

May 17, 2024
Cardiologist Heart Doctor Tablet Technology

TAVR, SAVR linked to comparable long-term outcomes, new meta-analysis confirms

Researchers tracked data from more than 7,500 patients, sharing their findings at EuroPCR 2024 in Paris and in JSCAI.

May 15, 2024
Edwards Lifesciences Sapien 3 Ultra Resilia TAVR

Updated balloon-expandable TAVR valve from Edwards outperforming its predecessors

The fifth-generation valve is associated with improved hemodynamic data and a reduced rate of paravalvular leak, according to new research published in JACC: Cardiovascular Interventions and EuroIntervention.

May 13, 2024
doctor examines patient data on their tablet

Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?

Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.

May 6, 2024
The DurAVR TAVR system from Anteris Technologies. A new biomimetic transcatheter aortic valve replacement (TAVR) system from Anteris Technologies could provide cardiologists with a new way to treat severe aortic stenosis (AS), according to new one-year data presented at SCAI 2024 Scientific Sessions, the annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI). The DurAVR TAVR system, made from a single piece of anti-calcification ADAPT tissue patented by Anteris.

New-look TAVR valve shows early promise in patients with severe AS

One-year data presented at SCAI's annual meeting suggest interventional cardiologists could soon have a new way to treat severe aortic stenosis.

May 3, 2024
A transcatheter aortic valve replacement (TAVR) procedure being performed at Intermountain Healthcare. Image from Intermountain Healthcare. Sex differences in TAVR one-year mortality.

TAVR linked to lower stroke risk than SAVR in patients with AS and cardiogenic shock

TAVR is also associated with a lower risk of acute kidney injury in this patient population. In-hospital mortality rates, however, are similar between the two treatment options. 

May 3, 2024

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup